McMaster University
Hamilton, Canada
Team details appear once the team leader joins.
Is this your team? Claim it
Haemophilia
FollowWhat is new in Haemophilia research, which clinical trials are open, and who works on it. From public registries and PubMed, with the source and date of every fact.
Cure status
- ANB-002Phase 3 · NCT06700096
- Antithrombin concentrate (ATIIIC)Phase 3 · NCT05662319 · NCT07285460
- Clotting factor concentrates (CFC) or bypassing agents (BPA)Phase 3 · NCT05662319 · NCT07285460
- ConcizumabPhase 3 · NCT05135559 · NCT04082429 · NCT04083781
- CSL222 (AAV5-hFIXco-Padua)Phase 3 · NCT06003387
- CSL222 (Adeno-associated viral vector serotype 5 [AAV5]-hFIXco-Padua)Phase 3 · NCT07080905
- DenecimigPhase 3 · NCT07830732
- Efanesoctocog alfaPhase 3 · NCT06716814
- efanesoctocog alfa (BIVV001)Phase 3 · NCT04644575
- EmicizumabPhase 3 · NCT05500807 · NCT07416604 · NCT04563520 · NCT04431726 · NCT05345197
- FEIBAPhase 3 · NCT04563520
- FitusiranPhase 3 · NCT05662319 · NCT07285460
- FRSW107Phase 3 · NCT06136507 · NCT07684898 · NCT07663903
- GS1191-0445 injectionPhase 3 · NCT07548411 · NCT06833983
- Human Coagulation Factor VIIIPhase 3 · NCT07416526
- KN057Phase 3 · NCT06312475 · NCT07545395 · NCT06569108 · NCT06747416
- MARSTACIMABPhase 3 · NCT06703606 · NCT05611801
- Mim8Phase 3 · NCT05685238
- NXT007Phase 3 · NCT07838194 · NCT05987449 · NCT07416604 · NCT07416526
- PF-06741086Phase 3 · NCT05145127
- PF-06838435/ fidanacogene elaparvovecPhase 3 · NCT03861273
- PF-07055480 (giroctocogene fitelparovec): Recombinant AAV2/6 Human Factor VIII Gene TherapyPhase 3 · NCT04370054
- Recombinant human activated coagulation factor VIII for injectionPhase 3 · NCT06297655
- rFVIIaPhase 3 · NCT04563520
- SCT800 prophylaxis and treatment for bleeding eventsPhase 3 · NCT07437404
- SKP-0141Phase 3 · NCT06738901
- SR604Phase 3 · NCT06349473 · NCT07644832 · NCT07876674
- STSP-0601 for InjectionPhase 3 · NCT06922045
- Valoctocogene roxaparvovecPhase 3 · NCT06224907
- Emicizumab InjectionPhase 2/3 · NCT06938659
- Factor VIII (FVIII)Phase 2/3 · NCT06938659
- Single dose intravenous injection of BBM-H803Phase 2/3 · NCT06111638
- Single dose intravenous injection of BBM-H901Phase 2/3 · NCT05203679
- Switching to low dose emicizumabPhase 2/3 · NCT07439055
- FoscenvivintPhase 2 · NCT07681089
- AAV2/8-HLP-FVIII-V3Phase 1/2 · NCT03001830
- ANB-002, dose 1Phase 1/2 · NCT06120582
- ANB-002, dose 2Phase 1/2 · NCT06120582
- ANB-002, dose 3Phase 1/2 · NCT06120582
- ANB-010, dose 1Phase 1/2 · NCT06185335
- ANB-010, dose 2Phase 1/2 · NCT06185335
- ANB-010, dose 3Phase 1/2 · NCT06185335
- ARD001Phase 1/2 · NCT07787091
- ASC618Phase 1/2 · NCT04676048
- AskBio009Phase 1/2 · NCT01687608
- LNP1265Phase 1/2 · NCT06379789
- REGV131Phase 1/2 · NCT06379789
- SPK-8011QQPhase 1/2 · NCT07226206
- ZS801Phase 1/2 · NCT05641610
- Auto CD34+PBSC, transduced with a lentiviral vector encoding the B domain deleted from of human coagulation factor VIIIPhase 1 · NCT03818763
- BBM-H901Phase 1 · NCT05709288
- Gene therapyPhase 1 · NCT04418414
- NNC0442-0344 APhase 1 · NCT07220564
- SCTB10Phase 1 · NCT07847697
- YUVA-GT-F801Phase 1 · NCT03217032
- YUVA-GT-F901Phase 1 · NCT03961243
- NGGT003Early phase 1 · NCT06238908
- Single dose intravenous injection of BBM 002Early phase 1 · NCT05454774
Closest to patients
- Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With InhibitorsResearch Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With InhibitorsRepublican Hospital n.a.V.A.Baranov · Petrozavodsk, Russia + 84 more hospitalsPhase 3Primary completion 2021
- Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without InhibitorsResearch Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without InhibitorsHamltn Hth Sci/McMstr Child Hosp · Hamilton, Canada + 95 more hospitalsPhase 3Primary completion 2022
- A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia BA Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia BMadison Radiological Group · Madison, United States + 58 more hospitalsPhase 3Primary completion 2022
Let us optimize your content
Apply for experimental treatment or a research study
The trial team decides who can take part; your doctor can help you ask.
Distance is calculated in your browser. Your city is not sent to us.
Loading trial sites…
Latest news
Results, new trials and publications, newest first. Every item links to its source.
Results and new studies, newest first, in plain words.
Plain-language summary pending. Original title shown.
Publication
Self-Reported Cannabis Use, Pain and Mental Health in People With Inheritable Bleeding Disorders.
Self-Reported Cannabis Use, Pain and Mental Health in People With Inheritable Bleeding Disorders.
Haemophilia : the official journal of the World Federation of Hemophilia
PubMed · PMID 42968604Publication
Pioglitazone and metformin attenuate hemophilic arthropathy progression via peroxisome proliferator-activated receptor signaling pathway activation.
Pioglitazone and metformin attenuate hemophilic arthropathy progression via peroxisome proliferator-activated receptor signaling pathway activation.
Journal of thrombosis and haemostasis : JTH
PubMed · PMID 42107709Publication
A Promising Frontier in Cancer Therapy - Combining Endothelial Colony Forming Cells, Nanotechnology, and Hyperthermia for Precision Oncology.
A Promising Frontier in Cancer Therapy - Combining Endothelial Colony Forming Cells, Nanotechnology, and Hyperthermia for Precision Oncology.
Stem cell reviews and reports
PubMed · PMID 40931311Publication
Lactobacillus and Allobaculum mediates the improvement of vascular endothelial dysfunction during hypertension with TaohongSiwu decoction combined with Dubosiella newyorkensis.
Lactobacillus and Allobaculum mediates the improvement of vascular endothelial dysfunction during hypertension with TaohongSiwu decoction combined with Dubosiella newyorkensis.
Heliyon
PubMed · PMID 38089998
Find fellow researchers
Groups with active Haemophilia work.
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy
Team details appear once the team leader joins.
Is this your team? Claim it
University Hospital Bonn
Bonn, Germany
Team details appear once the team leader joins.
Is this your team? Claim it
University of Milan
Milan, Italy
Team details appear once the team leader joins.
Is this your team? Claim it
Hospital Universitario La Paz
Madrid, Spain
Team details appear once the team leader joins.
Is this your team? Claim it
University of Washington
Seattle, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Pfizer (United States)
New York, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Azienda Ospedaliero-Universitaria Careggi
Florence, Italy
Team details appear once the team leader joins.
Is this your team? Claim it
University of Michigan
Ann Arbor, United States
Team details appear once the team leader joins.
Is this your team? Claim it
University Hospital Frankfurt
Frankfurt am Main, Germany
Team details appear once the team leader joins.
Is this your team? Claim it
Amsterdam University Medical Centers
Amsterdam, Netherlands
Team details appear once the team leader joins.
Is this your team? Claim it
University of Pennsylvania
Philadelphia, United States
Team details appear once the team leader joins.
Is this your team? Claim it